Consensus ESSA Pharma Inc. Toronto S.E.

Equities

End-of-day quote Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-.--%	-.--%

06/03	Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call
06/03	Norway's wealth fund pushes for more women on emerging market company boards	RE

d9edda48001.anWAszLotGeqCfF5JHArI4gqXDg3nkgDGXO3QZtq2eE.XyTf8Xaagh3rZcAsVS9vbLx-ak9uyz5IeCHfBdcdkYAcB-z8WduDHuJusA~cbfc3d518116300a7c793327ea1a1224

Oppenheimer Adjusts ESSA Pharma's Price Target to $17 From $23, Maintains Outperform Rating	14/22/14	MT
Oppenheimer Adjusts ESSA Pharma Price Target to $23 From $22, Maintains Outperform Rating	28/22/28	MT
Piper Sandler Adjusts ESSA Pharma's Price Target to $20 From $50, Reiterates Overweight Rating	12/22/12	MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $22 From $36 on Delayed EPI-7386 Clinical Update, Maintains Outperform Rating	17/21/17	MT
ESSA PHARMA : Piper Sandler Starts ESSA Pharma at Overweight With $50 Price Target	04/21/04	MT
ESSA PHARMA : HC Wainwright Adjusts ESSA Pharma PT to $32 From $36, Maintains Buy Rating	25/21/25	MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $36 From $20, Maintains Outperform Rating	12/21/12	MT
ESSA PHARMA : HC Wainwright & Co. Adjusts Price Target on ESSA Pharma to $36 From $17, Maintains Buy Rating	11/21/11	MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $20 From $9, Maintains Outperform Rating	14/21/14	MT
ESSA PHARMA : Jefferies Starts ESSA Pharma at Buy With $17 Price Target	02/20/02	MT

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.755 CAD

Average target price

26.69 CAD

Spread / Average Target

+244.12%

High Price Target

39.08 CAD

Spread / Highest target

+403.89%

Low Price Target

20.16 CAD

Spread / Lowest Target

+159.94%